Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-03

Clinical Trial Update: A Pilot Study of the Bioavailability of Nasal Naloxone [Phase 2]

View source ↗

Summary

Phase 2 pilot study assessing the bioavailability of nasal naloxone for drug overdose treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxone nasal formulation (Naloxone)

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Drug Overdose | Phase 2 | Status: COMPLETED